SEC - The United States Securities and Exchange Commission

02/05/2024 | Press release | Distributed by Public on 02/05/2024 12:42

Valeant Pharmaceuticals International, Inc. n/k/a Bausch Health Companies, Inc.; J. Michael Pearson; Howard B. Schiller; and Tanya R. Carro, CPA